Авторы заявляют об отсутствии конфликта интересов. Исследование проводилось объективно, без влияния со стороны спонсоров или иных заинтересованных сторон.
Ауталипов Дархан Хасанович является врачом ординатором отделения Голова и Шея ''University Medical Center'', опыт работы в детской ларингологии более 10 лет, является автором нескольких работ по оториноларингологии, публикаций в международных рецензируемых журналах
1. Gun ZH, Arif A, Boyce AM. Fibrous dysplasia in children and its management. Curr Opin Endocrinol Diabetes Obes. 2024;31(1):60-66. doi:10.1097/MED.00000000000008472. Szymczuk V, Taylor J, Boyce AM. Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications. Curr Osteoporos Rep. 2023;21(2):147-153. doi:10.1007/s11914-023-00779-63. Tucker-Bartley A, Selen DJ, Golden E, et al. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome. Int J Mol Sci. 2023;24(3):2550. Published 2023 Jan 29. doi:10.3390/ijms240325504. Szymczuk V, Taylor J, Michel Z, Sinaii N, Boyce AM. Skeletal Disease Acquisition in Fibrous Dysplasia: Natural History and Indicators of Lesion Progression in Children. J Bone Miner Res. 2022;37(8):1473-1478. doi:10.1002/jbmr.46185. Cherian KE, Paul TV. Inherited fibroblast growth factor 23 excess. Best Pract Res Clin Endocrinol Metab. 2024;38(2):101844. doi:10.1016/j.beem.2023.1018446. Fattah A, Khechoyan D, Phillips JH, Forrest CR. Paediatric craniofacial fibrous dysplasia: the Hospital for Sick Children experience and treatment philosophy. J Plast Reconstr Aesthet Surg. 2013;66(10):1346-1355. doi:10.1016/j.bjps.2013.05.0317. Ma J, Liang L, Gu B, Zhang H, Wen W, Liu H. A retrospective study on craniofacial fibrous dysplasia: preoperative serum alkaline phosphatase as a prognostic marker?. J Craniomaxillofac Surg. 2013;41(7):644-647. doi:10.1016/j.jcms.2012.12.0078. Rutkowski M, Niewinska K. The Epidemiology of Benign Proliferative Processes of the Skeletal System in Children. Int J Environ Res Public Health. 2021;18(17):9338. Published 2021 Sep 3. doi:10.3390/ijerph181793389. Vilos I, Nieminen MT, Mäkitie RE. Fibrous dysplasia of the head and neck in Southern Finland: a retrospective study on clinical characteristics, diagnostics, and treatment. Eur Arch Otorhinolaryngol. 2024;281(6):3189-3195. doi:10.1007/s00405-024-08595-z10. Golden E, van der Heijden H, Ren B, et al. Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome. J Clin Endocrinol Metab. 2024;109(3):771-782. doi:10.1210/clinem/dgad58911. Garg RK, O'Connor MK, Sterling DA, Jacob L, Hammoudeh JA, Andrews BT. Pediatric Odontogenic and Maxillofacial Bone Pathology: A Global Analysis. J Craniofac Surg. 2022;33(3):870-874. doi:10.1097/SCS.000000000000820112. Ghidei L, Bruno-Gaston JA, Guner JZ, Dietrich JE. Prevalence of Polycystic Ovary Syndrome in Patients With McCune Albright Syndrome. J Pediatr Adolesc Gynecol. 2022;35(1):48-52. doi:10.1016/j.jpag.2021.05.01413. Yang K, Ellenbogen Y, Algird AR, Sommer DD, Reddy K. Visual Outcomes After Endoscopic Endonasal Resection of Orbital Lesions. World Neurosurg. 2020;139:e501-e507. doi:10.1016/j.wneu.2020.04.05014. Benaessa MM, Mahomed F, Ngwenya SP. A retrospective clinico-pathologic analysis of cemento-osseous dysplasia in a South African patient population. Afr Health Sci. 2019;19(4):3154-3159. doi:10.4314/ahs.v19i4.3815. Brody A, Zalatnai A, Csomo K, Belik A, Dobo-Nagy C. Difficulties in the diagnosis of periapical translucencies and in the classification of cemento-osseous dysplasia. BMC Oral Health. 2019;19(1):139. Published 2019 Jul 10. doi:10.1186/s12903-019-0843-016. Meier ME, Vágó E, Abrahamsen B, et al. Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark. J Clin Endocrinol Metab. 2024;109(6):1423-1432. doi:10.1210/clinem/dgad74417. Carmoi T, Freche G. Dysplasie fibreuse polyostotique [Polyostotic fibrous dysplasia]. Rev Prat. 2022;72(9):990-991.18. Xu Y, Li Y, Dong H, et al. Craniofacial Fibrous Dysplasia in Fronto-Orbital Region: A Single-Center Retrospective Study of 38 Cases. World Neurosurg. 2024;181:e1130-e1137. doi:10.1016/j.wneu.2023.11.05419. Blum JD, Cho DY, Villavisanis DF, et al. The Natural History of Fibrous Dysplasia of the Orbit. Plast Reconstr Surg. 2024;153(5):962e-970e. doi:10.1097/PRS.000000000001068020. Bertin H, Huon JF, Guillot P, et al. Fibrous dysplasia of the orbital region: Series of 12 cases and review of the literature. J Fr Ophtalmol. 2020;43(6):467-476. doi:10.1016/j.jfo.2019.10.01221. van der Bruggen W, Hagelstein-Rotman M, de Geus-Oei LF, et al. Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2020;47(6):1527-1537. doi:10.1007/s00259-019-04657-122. Duarte PS, Sapienza MT. Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2020;47(6):1349-1350. doi:10.1007/s00259-020-04688-z23. Shi C, Li ZM, Sun HC. Zhonghua Kou Qiang Yi Xue Za Zhi. 2023;58(2):124-130. doi:10.3760/cma.j.cn112144-20220905-0047724. Mainville GN, Turgeon DP, Kauzman A. Diagnosis and management of benign fibro-osseous lesions of the jaws: a current review for the dental clinician. Oral Dis. 2017;23(4):440-450. doi:10.1111/odi.1253125. Ling Z, Xiao N, Li Y, et al. Differential expression profiles and function prediction of tRNA-derived fragments in fibrous dysplasia. Arch Oral Biol. 2022;135:105347. doi:10.1016/j.archoralbio.2022.10534726. Ma M, Liu L, Shi R, et al. Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws. Int J Oral Sci. 2021;13(1):21. Published 2021 Jun 30. doi:10.1038/s41368-021-00127-327. Shi RR, Li XF, Zhang R, Chen Y, Li TJ. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw. Mod Pathol. 2013;26(8):1023-1031. doi:10.1038/modpathol.2013.31